Liver Cirrhosis Completed Phase Trials for Rifaximin (DB01220)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02991612Rifaximin in Patients With Gastroesophageal Variceal BleedingTreatment
NCT01773538Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time MeasurementDiagnostic